Safety and tolerability of the combination of ATRA + arsenic trioxide (ATO) + gemtuzumab ozogamicin (GO) in high-risk acute promyelocytic leukemia (APL): Initial report of the SWOG/Alliance/ECOG S0535 trial Meeting Abstract
| Authors: | Lancet, J. E.; Othus, M.; DeAngelo, D. J.; Coutre, S.; Komrokji, R. S.; Tallman, M. S.; Litzow, M. R.; Appelbaum, F. R. |
| Abstract Title: | Safety and tolerability of the combination of ATRA + arsenic trioxide (ATO) + gemtuzumab ozogamicin (GO) in high-risk acute promyelocytic leukemia (APL): Initial report of the SWOG/Alliance/ECOG S0535 trial |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901552 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.7061 |
| Notes: | Meeting Abstract: 7016 -- Source: Wos |
